These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 11339007)

  • 41. Successful treatment of Graves disease in pregnancy with Lugol's iodine.
    Jamieson A; Semple CG
    Scott Med J; 2000 Feb; 45(1):20-1. PubMed ID: 10765530
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Usefulness of ultrasonic examination for evaluating the functional and morphologic state of the thyroid in patients with nontoxic and toxic parenchymal goiter].
    Widala E; Zych F
    Endokrynol Pol; 1993; 44(4):445-53. PubMed ID: 8055813
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lithium in the preoperative preparation of Graves' disease.
    Takami H
    Int Surg; 1994; 79(1):89-90. PubMed ID: 8063564
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content.
    Larsen PR
    J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Surgery still has a role in Graves' hyperthyroidism.
    Patwardhan NA; Moront M; Rao S; Rossi S; Braverman LE
    Surgery; 1993 Dec; 114(6):1108-12; discussion 1112-3. PubMed ID: 8256215
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pre-Operative Lugol's Iodine Treatment in the Management of Patients Undergoing Thyroidectomy for Graves' Disease: A Review of the Literature.
    Hope N; Kelly A
    Eur Thyroid J; 2017 Feb; 6(1):20-25. PubMed ID: 28611944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Color-flow Doppler sonography in Graves disease: "thyroid inferno".
    Ralls PW; Mayekawa DS; Lee KP; Colletti PM; Radin DR; Boswell WD; Halls JM
    AJR Am J Roentgenol; 1988 Apr; 150(4):781-4. PubMed ID: 3279732
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Scintigraphic findings of the thyroid in euthyroid ophthalmic Graves' disease.
    Kasagi K; Hidaka A; Misaki T; Miyamoto S; Takeuchi R; Sakahara H; Sasayama S; Iida Y; Konishi J
    J Nucl Med; 1994 May; 35(5):811-7. PubMed ID: 8176463
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [F-qi-FDG PET of the thyroid gland in Graves' disease].
    Börner AR; Voth E; Wienhard K; Wagner R; Schicha H
    Nuklearmedizin; 1998; 37(7):227-33. PubMed ID: 9830612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Thyroid gland hemiagenesis with Graves' disease].
    Mikosch P; Gallowitsch HJ; Kresnik E; Lind P
    Nuklearmedizin; 1999; 38(1):35-7. PubMed ID: 9987780
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The surgical treatment of hyperthyroid goiters--the current approach and the trends].
    Ganchev G; Sechanov T; Velkov M
    Khirurgiia (Sofiia); 1994; 47(2):14-6. PubMed ID: 7884997
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rescue pre-operative treatment with Lugol's solution in uncontrolled Graves' disease.
    Calissendorff J; Falhammar H
    Endocr Connect; 2017 May; 6(4):200-205. PubMed ID: 28325735
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Quantitative determination of echogenicity of diffuse inflammatory thyroid gland diseases].
    Happ J; Cordes U; Jost-Köstering S; Puhahn M
    Bildgebung; 1993 Sep; 60(3):131-4. PubMed ID: 8251734
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Color flow Doppler sonography rapidly differentiates type I and type II amiodarone-induced thyrotoxicosis.
    Bogazzi F; Bartalena L; Brogioni S; Mazzeo S; Vitti P; Burelli A; Bartolozzi C; Martino E
    Thyroid; 1997 Aug; 7(4):541-5. PubMed ID: 9292940
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Lugol's solution for preoperative pretreatment in Grave's disease].
    Dralle H
    Chirurg; 2019 Mar; 90(Suppl 2):108. PubMed ID: 30758612
    [No Abstract]   [Full Text] [Related]  

  • 56. An easy approach to ultrasonographic volumetry of the thyroid.
    Murakami T; Higaki N; Nishijima Y; Tani J; Noguchi H; Morisaki M; Eto M; Tani Y
    Endocr J; 2024 Jun; 71(6):617-621. PubMed ID: 38599853
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Thyroid morphology and function after surgical treatment of thyroid diseases.
    Mann B; Schmale P; Stremmel W
    Exp Clin Endocrinol Diabetes; 1996; 104(3):271-7. PubMed ID: 8817246
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Multicentre study of thyroid nodules in patients with Graves' disease.
    Kraimps JL; Bouin-Pineau MH; Mathonnet M; De Calan L; Ronceray J; Visset J; Marechaud R; Barbier J
    Br J Surg; 2000 Aug; 87(8):1111-3. PubMed ID: 10931060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Thyroid nodule in Basedow-Graves disease and thyroid cancer: experience in 6 patients].
    Piraino P; Sepúlveda A; Ibarra A; Michelsen H; Gac A; Pumarino H
    Rev Med Chil; 1995 Nov; 123(11):1402-8. PubMed ID: 8733284
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Iodine distribution in thyroid tissue taken from hyperthyroid patients treated with Lugol's solution or carbimazole.
    Etling N
    Rev Eur Etud Clin Biol; 1971; 16(7):662-7. PubMed ID: 4107371
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.